New York, NY – May 21, 2020 – Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today announces the second installment of its COVID-19 Virtual Conference Series to be hosted on M-Vest.com.
In this iteration of the M-Vest Infectious Disease Virtual Conference Series, panels involving 11 companies will focus on two key areas related to the ongoing pandemic; cell based therapies and testing.
Dr. McCarthy will lead discussions on recent developments in cell therapy for acute respiratory distress syndrome, or ARDS, a significant contributor to higher mortality in COVID-19. The second panel, entitled “Testing & Susceptibility – Clearing the Air”, will focus on developments in diagnostics and its integral role in responding to the current pandemic.
Register for free to hear from executives representing 11 biotech/pharma companies in various stages of development, from early-stage to commercialization.
Date: Wednesday, May 27, 2020
Time: 10:00am – 2pm ET
Cell therapy for ARDS – When Remdesivir is not enough
Testing & Susceptibility – Clearing the Air
If you are interested, please RSVP at https://m-vest.com/insights/blog/covid-19-virtual-conference.